252 related articles for article (PubMed ID: 20579254)
1. WARF's stem cell patents and tensions between public and private sector approaches to research.
Golden JM
J Law Med Ethics; 2010; 38(2):314-31. PubMed ID: 20579254
[TBL] [Abstract][Full Text] [Related]
2. Challenges to human embryonic stem cell patents.
Plomer A; Taymor KS; Scott CT
Cell Stem Cell; 2008 Jan; 2(1):13-7. PubMed ID: 18371416
[TBL] [Abstract][Full Text] [Related]
3. The ethics of patenting human embryonic stem cells.
Chapman AR
Kennedy Inst Ethics J; 2009 Sep; 19(3):261-88. PubMed ID: 19886524
[TBL] [Abstract][Full Text] [Related]
4. Law, science, and innovation: introduction to the symposium.
Robertson JA
J Law Med Ethics; 2010; 38(2):175-90. PubMed ID: 20579241
[No Abstract] [Full Text] [Related]
5. Regulating scientific research: intellectual property rights and the norms of science.
Rai AK
Northwest Univ Law Rev; 1999; 94(1):77-152. PubMed ID: 12784815
[No Abstract] [Full Text] [Related]
6. Patenting, morality and human embryonic stem cell science: bioethics and cultural politics in Europe.
Salter B
Regen Med; 2007 May; 2(3):301-11. PubMed ID: 17511566
[TBL] [Abstract][Full Text] [Related]
7. WARF's licensing policy for ES cell lines.
Gulbrandsen C
Nat Biotechnol; 2007 Apr; 25(4):387-8. PubMed ID: 17420736
[No Abstract] [Full Text] [Related]
8. Chimeras, moral status, and public policy: implications of the abortion debate for public policy on human/nonhuman chimera research.
Streiffer R
J Law Med Ethics; 2010; 38(2):238-50. PubMed ID: 20579247
[TBL] [Abstract][Full Text] [Related]
9. Embryonic stem cell research controversy: focus on the private sector and international sphere.
Kim S
Hastings Womens Law J; 2003; 14(1):89-108. PubMed ID: 16032810
[No Abstract] [Full Text] [Related]
10. Patently controversial: markets, morals, and the President's proposal for embryonic stem cell research.
Fins JJ; Schachter M
Kennedy Inst Ethics J; 2002 Sep; 12(3):265-78. PubMed ID: 12472079
[TBL] [Abstract][Full Text] [Related]
11. Stem cell research and economic promises.
Caulfield T
J Law Med Ethics; 2010; 38(2):303-13. PubMed ID: 20579253
[TBL] [Abstract][Full Text] [Related]
12. Ethics in public health research: a research protocol to evaluate the effectiveness of public-private partnerships as a means to improve health and welfare systems worldwide.
Barr DA
Am J Public Health; 2007 Jan; 97(1):19-25. PubMed ID: 17138922
[TBL] [Abstract][Full Text] [Related]
13. Battle lines shift in stem-cell funding fight...as non-profit companies enter the fray.
Smaglik P
Nature; 2000 May; 405(6782):6. PubMed ID: 10811186
[No Abstract] [Full Text] [Related]
14. Patenting human pluripotent cells: balancing commercial, academic and ethical interests.
Bahadur G; Morrison M
Hum Reprod; 2010 Jan; 25(1):14-21. PubMed ID: 19897856
[TBL] [Abstract][Full Text] [Related]
15. Embryonic stem cell patents and human dignity.
Resnik DB
Health Care Anal; 2007 Sep; 15(3):211-22. PubMed ID: 17922198
[TBL] [Abstract][Full Text] [Related]
16. Genome sequencing. Talks of public-private deal end in acrimony.
Marshall E
Science; 2000 Mar; 287(5459):1723-5. PubMed ID: 10755918
[No Abstract] [Full Text] [Related]
17. The role of the private sector in biotechnology: research and development.
Feisee L
Health Matrix Clevel; 2002; 12(2):357-65. PubMed ID: 12430359
[No Abstract] [Full Text] [Related]
18. Research ethics. The NIH draft guidelines on human stem cell research.
Majumder MA; Cohen CB
Science; 2009 Jun; 324(5935):1648-9. PubMed ID: 19556488
[No Abstract] [Full Text] [Related]
19. Political interventions in U.S. human embryo research: an ethical assessment.
Green RM
J Law Med Ethics; 2010; 38(2):220-8. PubMed ID: 20579245
[TBL] [Abstract][Full Text] [Related]
20. Will embryonic stem cells change health policy?
Sage WM
J Law Med Ethics; 2010; 38(2):342-51. PubMed ID: 20579256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
